Commodore Capital LP 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-16 4:10 pm Sale | 2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Commodore Capital LP | 0 0.000% | -3,711,286 (Position Closed) | Filing |
| 2022-02-14 4:10 pm Purchase | 2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Commodore Capital LP | 3,711,286 11.800% | 502,525 (+15.66%) | Filing |
| 2021-10-19 5:20 pm Purchase | 2021-10-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Commodore Capital LP | 3,208,761 10.200% | 1,089,516 (+51.41%) | Filing |
| 2021-03-15 07:57 am Purchase | 2021-03-03 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Commodore Capital LP | 2,119,245 6.700% | 2,119,245 (New Position) | Filing |